Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-653-7 | CAS number: 10294-26-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Epidemiological data
Administrative data
- Endpoint:
- epidemiological data
- Type of information:
- other: clinical field study in workers
- Adequacy of study:
- weight of evidence
- Reliability:
- other: Reliability was not assessed, because the publication was considered acceptable due to the fact that it served as a basis for OEL setting.
Data source
Reference
- Reference Type:
- publication
- Title:
- Potential nephrotoxic effects of exposure to silver.
- Author:
- Rosenman, K.D.; Seixas, N.; Jacobs, I.
- Year:
- 1 987
- Bibliographic source:
- British Journal of Industrial Medicine 44, 267-272
Materials and methods
- Study type:
- cross sectional study
- Endpoint addressed:
- repeated dose toxicity: inhalation
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A cross sectional study was conducted on workers engaged in manufacturing precious metal powder. Of the 27 workers, 96 % had raised urine silver concentrations and 92 % had raised blood silver concentrations. 19 % also had raised urine cadmium concentrations. The study examines the chronic effects of exposure to silver concentrating on the effects on renal function.
- GLP compliance:
- no
Test material
- Reference substance name:
- Silver nitrate
- EC Number:
- 231-853-9
- EC Name:
- Silver nitrate
- Cas Number:
- 7761-88-8
- Molecular formula:
- AgNO3
- IUPAC Name:
- Silver nitrate
- Reference substance name:
- silver oxide
- IUPAC Name:
- silver oxide
- Reference substance name:
- Silver chloride
- EC Number:
- 232-033-3
- EC Name:
- Silver chloride
- Cas Number:
- 7783-90-6
- Molecular formula:
- AgCl
- IUPAC Name:
- silver(1+) chloride
- Reference substance name:
- silver cadmium oxide
- IUPAC Name:
- silver cadmium oxide
- Reference substance name:
- silver metal
- IUPAC Name:
- silver metal
- Details on test material:
- Name of test material (as cited in study report): the company in which the study was undertaken produces silver nitrate, silver oxide, silver chloride and silver cadmium oxide powders; in addition silver metal ingots are produced.
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Constituent 5
Method
- Type of population:
- occupational
- Ethical approval:
- not specified
- Details on study design:
- METHOD OF DATA COLLECTION
Type: Questionnaire / Work history / Clinical tests
Details:
- Testing consisted of a detailed questionnaire.
- Slit lamp examination was conducted by an ophthalmologist (conjunctival and corneal finding were coded on a 1-4 scale).
- Measurement of weight, urinary concentration of silver and cadmium, blood silver concentration, blood chemistry including blood urea nitrogen, and creatine and urinary n-acetyl-B-D glucosaminidase (NAG). Estimated creatine clearance was calculated. Analysis for cadmium, silver and NAG were performed on spot urine samples. Urine silver and cadmium levels were reported as micrograms of metal per litre of urine. For all analysis relating urine metal concentrations with health effects, however, the urine metal levels were corrected for urine concentration by expressing them as micrograms of metal per milligram creatine.
- An additional analysis of the effect of silver on NAG and creatinine clearance was conducted by comparing urinary NAG in the group as a whole with results of NAG in an unexposed control population consisting of the first 28 of 51 male workers from a tungsten carbide machine shop who were being studied for effects of tungsten carbide and cobalt.
SETTING:
- The company in which the study was undertaken produces silver nitrate, silver oxide, silver chloride and silver cadmium oxide powders; in addition silver metal ingots are produced.
- About 220 workers are employed at the plant (incl. 30 maintenance workers and 150 in production).
STUDY POPULATION
- All employees who had worked for at least two years in silver flake, silver nitrate, silver powder, or the refinery area.
- Maintenance workers who had worked for more than five years at the plant-
- Workers from any area who had worked for more than 10 years were asked to participate and 27 workers agreed to do so.
COMPARISON POPULATION
- Type: control or reference group.
- Details: unexposed control population consisting of the first 28 of 51 male workers from a tungsten carbide machine shop who were being studied for effects of tungsten carbide and cobalt. - Exposure assessment:
- measured
- Details on exposure:
- A federal Occupational Safety and Health Administration health inspection was conducted at the plant and time weighed exposures to silver ranged from 0.04 – 0.35 mm/m3.
- Statistical methods:
- Multiple regression analysis
Results and discussion
- Results:
- FINDINGS
- Of the 27 workers, 96% had raised urine silver concentrations (range 0.5-52.0 µg/l, mean 1.3 mg/l).
- 92% of workers had raised blood silver concentrations (range 0.05-6.2 µg/100 ml, mean 1.0 µg/100 ml).
- 90% had raised urinary cadmium concentrations (range 1.9-76.0 µg/l, mean 11.8 µg/l).
- Most workers had symptoms of respiratory irritation; nose bleeds were reported in 30%.
- Deposition of silver in the cornea and conjunctivae of the eyes was observed in five of eight long-term workers (63%).
- In total, 10 of 27 workers (37%) showed conjunctival deposition, and 6 of 27 workers (22%) corneal deposition of silver.
- Although not statistically significant, corneal deposition was associated with complaints about decreased night vision.
- The urinary enzyme NAG was significantly raised in four individuals and was correlated with blood silver concentrations and age.
- Average NAG concentrations were significantly higher in silver exposed subjects than in the control population.
- Estimated creatinine clearance was significantly lower in the silver exposed group.
- Kidney function appeared to be adversely affected because of the exposure to cadmium. - Strengths and weaknesses:
- - The small group of subjects limited the statistical power of the findings and precluded definite conclusions of rates of illness in the whole population.
- Limited information on actual environmental levels of silver exposure or air contaminats was obtained.
Applicant's summary and conclusion
- Conclusions:
- Exposure to silver compounds such as silver oxide and nitrate caused irritation of the eye, nose and throat in 15 out of 27 workers; nine had respiratory symptoms (cough, wheezing and chest tightnes) and eight complained of nose bleeds. Some individual with long-term exposure had conjunctival deposition and corneal opacities (63%), and were more likely to report problems with night vision.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.